{
  "id": "621b99973a8413c653000045",
  "type": "summary",
  "question": "What is the human proteoform project?",
  "ideal_answer": "Top-down proteomics is emerging as a preferred approach to investigate biological systems, with objectives ranging from the detailed assessment of a single protein therapeutic, to the complete characterization of every possible protein including their modifications, which define the human proteoform.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34767442",
    "http://www.ncbi.nlm.nih.gov/pubmed/32118252",
    "http://www.ncbi.nlm.nih.gov/pubmed/34539228",
    "http://www.ncbi.nlm.nih.gov/pubmed/34047392",
    "http://www.ncbi.nlm.nih.gov/pubmed/34472376",
    "http://www.ncbi.nlm.nih.gov/pubmed/32967423"
  ],
  "snippets": [
    {
      "text": "Top-down proteomics is emerging as a preferred approach to investigate biological systems, with objectives ranging from the detailed assessment of a single protein therapeutic, to the complete characterization of every possible protein including their modifications, which define the human proteoform.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34047392",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "intact mass data are readily deconvoluted using well-known software options, the analysis of fragmentation data that result from a tandem MS experiment - essential for proteoform characterization - is not yet standardized",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34539228",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background ApoAI (apolipoproteins AI) and apoAII (apolipoprotein AII) are structural and functional proteins of high-density lipoproteins (HDL) which undergo post-translational modifications at specific residues, creating distinct proteoforms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34472376",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": ". Characterizing proteoforms involves identifying and locating primary structure alterations (PSAs) in proteoforms, which is of practical importance for the advancement of the medical profession. With the development of mass spectrometry (MS) technology, the characterization of proteoforms based on top-down MS technology has become possible. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32118252",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Proteoforms are the workhorses of the cell, and subtle differences between their amino acid sequences or post-translational modifications (PTMs) can change their biological function.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32967423",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}